Biotech · Private company
Diasome Pharmaceuticals
Track this companyFree. Adds Diasome Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Oral Hepatic Directed Vesicles (HDV)-Insulin (U-15)Phase 3 · DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Oral Hepatic Directed Vesicles (HDV)-Insulin (U-5)Phase 3 · DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- HDV-Insulin Lispro and Insulin Degludec (-10%)Phase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- HDV-Insulin Lispro and Insulin Degludec (-40%)Phase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- HDV-LisproPhase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- LisproPhase 2 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin DegludecPHASE2 · COMPLETED · started Dec 28, 2023ClinicalTrials.gov NCT06238778 · fetched Nov 12, 2026
- Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin DegludecPHASE2 · COMPLETED · started Mar 18, 2019ClinicalTrials.gov NCT03938740 · fetched Nov 12, 2026
- Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes MellitusPHASE2_PHASE3 · COMPLETED · started Dec 1, 2008ClinicalTrials.gov NCT00814294 · fetched Nov 12, 2026
- A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes MellitusCOMPLETED · started Sep 17, 2007ClinicalTrials.gov NCT00521378 · fetched Nov 12, 2026